Counteracting antibiotic resistance enzymes and efflux pumps

M Zheng, TJ Lupoli - Current opinion in microbiology, 2023 - Elsevier
Highlights•Adjuvants potentiate existing antibiotics or combat mechanisms of
resistance.•Probes enable the identification of enzymes that modify tuberculosis …

An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another …

PJ Simner, Y Bergman, R Conzemius… - Open Forum …, 2023 - academic.oup.com
Background Cefiderocol and ceftazidime-avibactam plus aztreonam (CZA-ATM) are
preferred treatment regimens for New Delhi metallo-β-lactamase (NDM)-producing …

In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae

X Li, Z Chen, J Jiao, S Wang, Y Wang… - Expert Review of Anti …, 2023 - Taylor & Francis
Background Antibiotic resistance has become a public health problem to be solved
worldwide and metallo-β-lactamase (MBL)-producing bacteria make this problem even more …

Identification of isothiazolones analogues as potent bactericidal agents against antibiotic resistant CRE and MRSA strains

W Jin, C Xu, N Dong, K Chen, D Zhang, J Ning, Y Li… - BMC chemistry, 2023 - Springer
Carbapenem-resistant Enterobacterales (CRE) has emerged as a worldwide spread
nosocomial superbug exhibiting antimicrobial resistance (AMR) to all current antibiotics …

Extreme resistance to the novel siderophore-cephalosporin cefiderocol in an extensively drug-resistant Klebsiella pneumoniae strain causing fatal pneumonia with …

L Daoud, M Allam, T Collyns, A Ghazawi… - European Journal of …, 2023 - Springer
Cefiderocol (CFDC) is the first-in-class siderophore-cephalosporin. Klebsiella pneumoniae
strain that is extremely resistant to CFDC (MIC: 256 µg/ml) was isolated for the first time in …

Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in Enterobacterales

J Wachino, W Jin, C Norizuki, K Kimura… - Microbiology …, 2024 - Am Soc Microbiol
ABSTRACT Metallo-β-lactamases (MBLs) represent one of the main causes of carbapenem
resistance in the order Enterobacterales. To combat MBL-producing carbapenem-resistant …

Drug Discovery in the Field of β-Lactams: An Academic Perspective

LMC Jacobs, P Consol, Y Chen - Antibiotics, 2024 - mdpi.com
β-Lactams are the most widely prescribed class of antibiotics that inhibit penicillin-binding
proteins (PBPs), particularly transpeptidases that function in peptidoglycan synthesis. A …

Inhibition of β-lactamase function by de novo designed peptide

A Mishra, I Cosic, I Loncarevic, D Cosic, HM Fletcher - Plos one, 2023 - journals.plos.org
Antimicrobial resistance is a great public health concern that is now described as a “silent
pandemic”. The global burden of antimicrobial resistance requires new antibacterial …

Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors

MJ Rotter, S Zentgraf, L Weizel, D Frank, LD Burgers… - Molecules, 2023 - mdpi.com
Metallo beta lactamases (MBLs) are among the most problematic resistance mechanisms of
multidrug-resistant Gram-negative pathogens due to their broad substrate spectrum and lack …

Metallo-β-lactamases

E Denakpo, G Arlet, A Philippon, BI Iorga - Metalloenzymes, 2024 - Elsevier
Abstract Metallo-β-lactamases (MBLs) are a class of enzymes that are produced by a variety
of bacterial species and are responsible for conferring resistance to a broad range of β …